Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOVITA A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.7% 0.7% 0.7% 0.6% 2.8% 2.1% 9.6% 9.6%   Credit score (0-100)   96 95 95 97 59 66 26 26   Credit rating   AA AA AA AA BBB BBB BB BB   Credit limit (kDKK)   472.6 418.6 506.8 610.1 0.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,691 2,557 2,496 2,691 2,403 2,878 0.0 0.0   EBITDA   1,350 948 951 1,057 560 989 0.0 0.0   EBIT   1,219 817 850 957 560 989 0.0 0.0   Pre-tax profit (PTP)   1,168.3 731.2 774.3 853.6 529.5 942.3 0.0 0.0   Net earnings   910.4 569.6 603.8 665.2 402.0 739.4 0.0 0.0   Pre-tax profit without non-rec. items   1,168 731 774 854 529 942 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   4,159 4,058 3,958 3,857 0.0 0.0 0.0 0.0   Shareholders equity total   3,618 3,588 4,081 4,633 2,883 3,422 1,922 1,922   Interest-bearing liabilities   1,692 2,029 1,899 1,840 197 342 0.0 0.0   Balance sheet total (assets)   7,254 7,154 7,579 8,064 4,060 4,669 1,922 1,922   Net Debt   881 1,818 850 350 -83.6 -1,113 -1,922 -1,922     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,691 2,557 2,496 2,691 2,403 2,878 0.0 0.0   Gross profit growth   4.0% -5.0% -2.4% 7.8% -10.7% 19.8% -100.0% 0.0%   Employees   3 3 3 3 3 3 0 0   Employee growth %   -25.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,254 7,154 7,579 8,064 4,060 4,669 1,922 1,922   Balance sheet change%   0.4% -1.4% 5.9% 6.4% -49.6% 15.0% -58.8% 0.0%   Added value   1,350.3 948.0 950.9 1,057.4 661.0 989.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -262 -262 -201 -210 -3,462 -395 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   45.3% 31.9% 34.1% 35.6% 23.3% 34.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   17.2% 11.3% 11.5% 12.2% 9.2% 22.7% 0.0% 0.0%   ROI %   21.9% 13.8% 13.5% 14.3% 11.2% 29.0% 0.0% 0.0%   ROE %   27.7% 15.8% 15.7% 15.3% 10.7% 23.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   49.9% 50.6% 53.8% 57.5% 71.0% 73.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   65.2% 191.8% 89.3% 33.1% -14.9% -112.5% 0.0% 0.0%   Gearing %   46.8% 56.6% 46.5% 39.7% 6.8% 10.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 4.6% 3.9% 5.5% 3.0% 18.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.8 1.2 1.5 1.3 1.9 0.0 0.0   Current Ratio   1.9 2.0 2.3 2.6 3.4 3.7 0.0 0.0   Cash and cash equivalent   810.9 210.9 1,049.2 1,490.2 280.3 1,455.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,476.1 1,561.2 2,023.8 2,612.7 2,882.7 3,422.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   450 316 317 352 220 330 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   450 316 317 352 187 330 0 0   EBIT / employee   406 272 283 319 187 330 0 0   Net earnings / employee   303 190 201 222 134 246 0 0